Pictured: incoming PGY1 class
#pharmacy #residency
Pictured: incoming PGY1 class
#pharmacy #residency
@sidpharm.bsky.social
@sidpharm.bsky.social
Pharmacists lead innovation in ID & make a huge impact on patient care! Don't forget to join us today from 12-1PMEST to celebrate!
Pharmacists lead innovation in ID & make a huge impact on patient care! Don't forget to join us today from 12-1PMEST to celebrate!
Dr. Brent Richards joins Dr. Erin McCreary to discuss the growing capability for AI and big data in the healthcare industry. What is AI & machine learning, how can these tools enhance patient care, and what can we expect in the future from this space?
🎧 sidp.pinecast.co
Dr. Brent Richards joins Dr. Erin McCreary to discuss the growing capability for AI and big data in the healthcare industry. What is AI & machine learning, how can these tools enhance patient care, and what can we expect in the future from this space?
🎧 sidp.pinecast.co
Drs. Amy Mathers & Julie Ann Justo join Dr. Erin McCreary to talk all things Steno! Hear from the experts on how to optimize abx regimens in the setting of true infections. This medical education was provided by an unrestricted grant from Shionogi.
🎧 sidp.pinecast.co
Drs. Amy Mathers & Julie Ann Justo join Dr. Erin McCreary to talk all things Steno! Hear from the experts on how to optimize abx regimens in the setting of true infections. This medical education was provided by an unrestricted grant from Shionogi.
🎧 sidp.pinecast.co
Led by @olivercornely.bsky.social @rosannesprute.bsky.social with contributions from >100 experts
Author link: authors.elsevier.com/sd/article/S... #IDSky
Led by @olivercornely.bsky.social @rosannesprute.bsky.social with contributions from >100 experts
Author link: authors.elsevier.com/sd/article/S... #IDSky
FLQ-S, Rif-R TB non-inferiority trial with 5(!) different 9 month regimens vs standard care
Beware: alphabet soup
3 regimens were non-inferior in mITT and per-protocol analyses:
- BLMZ
- BCLLfxZ
- BDLLfxZ
Adds to BPaLM
#IDSky #TBSky
www.nejm.org/doi/full/10....
FLQ-S, Rif-R TB non-inferiority trial with 5(!) different 9 month regimens vs standard care
Beware: alphabet soup
3 regimens were non-inferior in mITT and per-protocol analyses:
- BLMZ
- BCLLfxZ
- BDLLfxZ
Adds to BPaLM
#IDSky #TBSky
www.nejm.org/doi/full/10....
doi.org/10.1016/S014...
#IDSky
doi.org/10.1016/S014...
#IDSky